12986
Similar to reports in patients receiving gefitinib , those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity .
 adverse effect: pulmonary fibrosis, erlotinib; adverse effect: pulmonary toxicity, erlotinib
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  pulmonary fibrosis, erlotinib; pulmonary toxicity, erlotinib 
Answer:
 adverse effect: pulmonary fibrosis, erlotinib; adverse effect: pulmonary toxicity, erlotinib